Evaluation of lipophilicity and antitumour activity of parallel carboxamide libraries

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 780, Issue 2, 2002, Pages 355-363

  Hollósy, Ferenc ^a   Seprödi, János ^a   örfi, László ^a   Erös, Dániel ^a   Kéri, György ^a   Idei, Miklós ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Carboxamide parallel library; Lipophilicity

Indexed keywords

AMIDE; ANTINEOPLASTIC AGENT; LIPID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FURAN DERIVATIVE; THIOPHENE DERIVATIVE;

ARTICLE; CHEMISTRY; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; ANTINEOPLASTIC ACTIVITY; CELL LINE; CELL PROLIFERATION; COLORIMETRY; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIPOPHILICITY; MATHEMATICAL ANALYSIS; PREDICTION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMIDES; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIPIDS;

AROMATIC COMPOUNDS; BIOASSAY; BIOSYNTHESIS; CELLS; MOLECULES; SUBSTITUTION REACTIONS; TUMORS;

LIPOPHILICITY;

CHROMATOGRAPHIC ANALYSIS;

EID: 0037175434     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)00545-7     Document Type: Article

References (37)

1. Ghose A.K., Viswanadhan V.N., Wendoloski J.J. J. Comb. Chem. 1:1999;55.
2. Frank J., Dormán G., ComGenex Scientific Newsletter. Eurocombi-1 Conference Special edition, 2001.
3. Hansch C., Fujita T. J. Am. Soc. Chem. Rev. 91:1971;525.
4. Leo A., Hansch C., Elkins D. Chem. Rev. 91:1971;525.
5. Hansch A.L. Chem. Rev. 91:1993;1281.
6. Mannhold R., Kubinyi H., Timmerman H. Pilska V., Testa B., van de Waterbeemd H., Methods and Principles in Medicinal Chemistry. Lipophilicity in Drug Action and Toxicology. Vol. 4:1996;Verlag Chemie, Weinheim.
7. Minick J.D., Sabatka J.J., Shumaker T.K., Hodgson G.L., Brent D.A. J. Liq. Chromatogr. 10:1987;2565.
8. Sabatka J.J., Minick D.J., Shumaker T.K., Hodgson G.L., Brent D.A. J. Chromatogr. 384:1987;349.
9. Kaliszan R. Quantitative Structure-Chromatographic Retention Relationships. 1987;Wiley Interscience, New York.
10. Dross K., Sonntag C., Mannhold R. J. Chromatogr. 673:1994;113.
11. Gluck S.J., Martin E.J. J. Liq. Chromatogr. 13:1990;2529.
12. Khaledi M.G., Breyer E.D. Anal. Chem. 61:1989;1040.
13. Gag F., Alvarez-Buil J., Elguero J., Diez-Masa J.C. Anal. Chem. 59:1987;921.
14. Clifford D.R., Watkins D.M. Pestic. Sci. 2:1971;41.
15. Valkó K., Plass M., Bevan C., Reynolds D., Abraham M.H. J. Chromatogr. A. 797:1998;41.
16. Kaliszan R. Brown P.R., Grushka E., Advances in Chromatography. 1993;147 Marcel Dekker, New York.
17. Dorsey J.G., Khaledi M.G. J. Chromatogr. 656:1993;485.
18. Hsieh M.M., Dorsey J.G. J. Chromatogr. 631:1993;63.
19. Valkó K. Kalász H., Ettre L., Chromatography, The State of the Art. 1985;739 Akadémia, Budapest.
20. Valkó K., Bevan C., Reynolds D. Anal. Chem. 69:1997;2022.
21. Xue L., Bajorath J. Comb. Chem. High Throughput Screen. 3:2000;363.
22. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23:1997;3.
23. Darvas F., Dormán G. Chim. Oggi. 17:1999;10.
24. Leahy D.E., Duncan R., Ahr H.J., Bayliss M.K., Boer A.G., Darvas F., Fentem J.H., Fry J.R., Hopkins R., Houston J.B., Karlsson J., Kedderis G.L., Pratten M.K., Prieto P., Smith D.A., Straughan D.W. Pharmacokinetics in early drug research. Fentem J.H., The Report and Recommendations of ECVAM Workshop 22. ATLA 25. 1997;17 Russell and Burch House, Nottingham, UK.
25. Erhardt P.W. Drug metabolism data: past, present and future considerations. Erhardt P.W., Drug Metabolism, Databases and High-Throughput Testing During Drug Design and Development. 1999;2 Blackwell Science, Cambridge, MA.
26. Martin A., Clynes M. Cytotechnology. 11:1993;49.
27. Roehm N.W., Rodgers G.H., Hatfield S.M., Glasebrook A.L. J. Immunol. Methods. 142:1991;257.
28. Berridge M.V., Tan A.S., McKoy K.D., Wang R. Biochemistry. 4:1996;15.
29. Hollósy F., Mészáros G., Bökönyi G., Idei M., Seprödi J., Szende B., Kéri G. Anticancer Res. 20:2000;4563.
30. Hollósy F., Lóránd T., örfi L., Erös D., Kéri G., Idei M. J. Chromatogr. B. 768:2002;361.
31. Hollósy F., Lóránd T., örfi L., Erös D., Kéri G., Idei M. J. Liq. Chromatogr. Relat. Technol. 25:2002;1129.
32. Schröder E., Lübke K. The peptides. Methods of Peptide Synthesis. Vol. 1:1965;76 Academic Press, New York.
33. Takács-Novák K. Acta Pharm. Hung. 68:1998;39.
34. Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. 1979;Wiley, New York.
35. Spalding D.J.M. Drug Discov. Today. 5:2001;S70.
36. de Julian-Ortiz J.V. Comb. Chem. High Throughput Screen. 4:2001;295.
37. Kubinyi H., Folkers G., Martin Y.C., 3D-QSAR in Drug Design. Vol. 2:1998;Kluwer Academic Publishers, Dordrecht.